Allan W. Nicholas

1.7k citations
15 papers · 1.5k indexed · 1 hit paper · h-index 11
Topics
Cancer therapeutics and mechanisms (9 papers)Bioactive Compounds and Antitumor Agents (5 papers)Microbial Natural Products and Biosynthesis (3 papers)
Partner nations
United States

In The Last Decade

Allan W. Nicholas

15 papers receiving 1.4k citations

Hit Papers

DNA Topoisomerase I—Targeted Chemotherapy of Human Colon ...19892026200120131989100200300400500

Peers

Allan W. Nicholas
Comparison fields: 5 of 67
  • Molecular Biology 1.3k
  • Oncology 758
  • Toxicology 384
  • Organic Chemistry 235
  • Pharmacology 195
Replace T Furuta with:
T Furuta Japan
Elaine Willmore United Kingdom
Jean‐Marc Barret France
Cristina Geroni Italy
A Monks United States
Hiroharu Arakawa Japan
Fabio Animati Italy
Baguley Bc New Zealand
Satyakam Singh United States
Reshma Rani India
Allan W. Nicholas relative to T Furuta Japan T Furuta's profile →
Citations per field
00.5×1.5×2.0×
T Furuta · 1×
Citations per year

Countries citing papers authored by Allan W. Nicholas

Since Specialization
Citations

This map shows the geographic impact of Allan W. Nicholas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan W. Nicholas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan W. Nicholas more than expected).

Fields of papers citing papers by Allan W. Nicholas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan W. Nicholas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan W. Nicholas. The network helps show where Allan W. Nicholas may publish in the future.

Co-authorship network of co-authors of Allan W. Nicholas

This figure shows the co-authorship network connecting the top 25 collaborators of Allan W. Nicholas. A scholar is included among the top collaborators of Allan W. Nicholas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan W. Nicholas. Allan W. Nicholas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 120
2 3
3 62
4 6
5
DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenograftsbreakdown →
568
6
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
307
7 99
8 93
9 56
10 112
11 25
12 19
13 10
14 8
15 2

About Allan W. Nicholas

Allan W. Nicholas is a scholar working on Toxicology, Complementary and alternative medicine and Pharmacology, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Microbial Natural Products and Biosynthesis (3 papers). The work is most often cited by research in Toxicology (384 citations), Oncology (758 citations) and Molecular Biology (1.3k citations). Allan W. Nicholas has collaborated with scholars based in United States. Frequent co-authors include Monroe E. Wall, Mansukh C. Wani, M Potmĕsil, Leroy F. Liu, Govindarajan Manikumar, Mansukh C. Wani, Robert Silber, Beppino C. Giovanella, John S. Stehlin and S Kirschenbaum. Their work appears in journals such as Science, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026